The human neuroblastoma cell line IMR-32 exhibits both cholinergic and adrenergic properties.
We have used IMR-32 cells to study the effects of CDF (CAT development factor) and bFGF (basic fibroblast growth factor) on the development of neurotransmitter properties. CDF treatment increases CAT activity in a dose-dependent manner, independent of cell density. Time course studies show that there is a threefold increase in the specific CAT activity in IMR-32 cells treated with CDF for 6 d. CDF does not, however, affect the level of tyrosine hydroxylase (TH) activity, or the rate of cell proliferation.
bFGF, on the other hand, induces TH activity and decreases CAT activity in a dose-dependent manner. bFGF's effect on TH is enhanced by increasing cell density, while its reduction of specific CAT activity is independent of ceil density. Time course studies show a 30-fold increase in TH activity per cell and a threefold decrease in CAT activity per cell, after treatment with bFGF for 6 d. In contrast to the effects of CDF, bFGF enhances cell proliferation in IMR-32 cells. Double-labeled immunofluorescence studies showed that 95% of the cells stain for CAT and 65% stain for TH following treatment with CDF and bFGF, respectively. When these factors are combined, approximately 75% of the cells express both CAT and TH, demonstrating that IMR-32 cells are bipotential with regard to neurotransmitter-associated enzyme expression.
We also show that insulin-like growth factor I and NGF selectively induce CAT activity and cell proliferation, respectively, whereas epidermal growth factor has no effect. Thus, IMR-32 cells appear to be differentially responsive to distinct neurotrophic factors and also provide a model for studying the specific effects of neurotrophic factors on functional differentiation.
The functional maturation of neurons involves the acquisition of an efficient mechanism for the synthesis and release of neurotransmitters. Although the processes that regulate the development of functional phenotype are poorly understood, there is increasing evidence that target-derived factors may influence the choice ofneurotransmitter phenotype (Patterson, 1978; Lan-dis and Keefe, 1983; Schotzinger and Landis, 1990) as well as the timing and level of neurotransmitter enzyme expression in neurons with an established phenotype (Vaca, 1988) . In vitro experiments have shown that extracts of cholinergic and adrenergic target tissues contain substances that influence the development of these properties in PNS and CNS neurons (Patterson and Chun, 1974; Prochiantz et al., 198 1; Swerts et al., 1983; Tomozawa and Appel, 1986; McManaman et al., 1988) . Although a number of these factors have been isolated and identified (Thoenen and Barde, 1980; Barde et al., 1982; McManaman et al., 1988; Adler et al., 1989; Yamamori et al., 1989) , their cellular and phenotypic specificities have not been well characterized. Neuronal cell lines have been used previously to characterize the cellular and biochemical effects of neurotrophic factors (Pavelic and Spaventi, 1987; Rydel and Greene, 1987; Schubert et al., 1987; Pollock et al., 1990) . Furthermore, neuronal lines that express multiple neurotransmitter enzymes provide a means of characterizing and comparing the effects of specific neurotrophic factors on differential phenotypic expression. The IMR-32 human neuroblastoma cell line expresses both cholinergic and adrenergic neurotransmitter properties (Tumilowicz et al., 1970; Schlesinger et al., 1976; West et al., 1977; Thompson et al., 1982) . This cell line has previously been used to study the effects of NGF and bFGF (basic fibroblast growth factor) on growth and morphological differentiation (Reynolds and Perez-Polo, 198 1; Sonnenfeld and Ishii, 1982; Ludecke and Unsicker, 1990) .
In the present studies, the IMR-32 cell line was used to characterize the phenotypic specificities of CDF (CAT development factor), a newly identified neurotrophic factor from skeletal muscle; bFGF, NGF, IGF-I (insulin-like growth factor I); and EGF (epidermal growth factor). CDF is a 22-24 kDa acidic protein from rat skeletal muscle that has been shown to enhance CAT in both unfractionated and motoneuron-enriched cultures of embryonic rat spinal cord cells (McManaman et al., 1990) . Recent studies have demonstrated that this factor also selectively rescues embryonic chick motoneurons from cell death in vivo (McManaman et al., 1990) and stimulates CAT expression in the human neuroblastoma cell line LA-N-2 (McManaman and Crawford, 1991) . The biochemical properties of CDF distinguish it from other factors that influence the phenotypic properties of neurons, such as NGF; bFGF, IGF-I, -11, and -111; EGF; and LIF (leukemia inhibitory factor) (McManaman et al., 1988) . CDF is further distinguished from CNTF (ciliary neurotrophic factor) based on differences in p1, N- IMR-32 cells were cultured with 5 nM CDF (A) or 3 nM bFGF (O), or without factors (m and assayed for CAT activity on days O-6. The effects of these treatments on CAT activity (CAT/cell) are shown as the percentage of the day 0 CAT activity. Each value is the average + SD of triplicate culture wells.
in rat skeletal muscle (Stockli et al., 1989) . NGF is the bestcharacterized neurotrophic factor and thus far the only factor with an established role in the expression of neurotransmitter properties (Thoenen and Barde, 1980; Vantini et al., 1989) . NGF has been shown to enhance CAT expression in cultures of septal neurons (Hefti et al., 1985a; Knusel et al., 1990) , tyrosine hydroxylase (TH) expression in cultures of sympathetic neurons (Naujoks et al., 1982) , and both CAT and TH in PC-12 cells (Schubert et al., 1977; Hatanaka, 198 1; Lee et al., 1985) . bFGF, IGF-I, and EGF are best known as mitogenic growth factors (Carpenter and Cohen, 1976; Gospodarowicz et al., 1986; Mattsson et al., 1986) . However, these factors also affect neurotransmitter phenotype and neuronal development. IGF-I increases CAT activity in rat septal cells (Knusel et al., 1990) and TH activity in chick dorsal root ganglia (Xue et al., 1988) , whereas EGF induces TH activity and TH mRNA expression in the pheochromocytoma cell line PC-G2 (Goodman et al., 1980; Lewis and Chikaraishi, 1987) and CAT in PC-12 cells (McManaman and Crawford, 1991) . bFGF induces CAT activity in rat septal cells (Knusel et al., 1990) , rat spinal cord cultures (McManaman et al., 1989) , and PC-12 cells (McManaman and Crawford, 199 1) . We have recently shown that CDF and bFGF have distinct and additive effects on the choline& properties of cultured embryonic spinal cord and the LA-N-2 human neuroblastoma cell line (McManaman et al., 1989; McManaman and Crawford, 199 1) .
In this study, we examine the effects of these factors on CAT and TH induction in a cell line that exhibits both cholinergic and adrenergic properties. Our findings demonstrate that the factors vary in their abilities to induce phenotypic changes and show that two of these factors (CDF and bFGF) have opposing effects on phenotypic expression within a single cell.
Materials and Methods
Dulbecco's Modified Eagle's Medium (DMEM), glutamine, penicillin, streptomycin, nonessential amino acids, and sodium pyruvate were purchased from GIBCO (Grand Island. NY). Trvnsin and general chemicals were obtained from Sigma (St. Louis, MO): Fetal bo;ine serum (FBS) was purchased from Hyclone Labs (Logan, UT). 3H-acetyl-coenzyme A (CoA) and 'H-thymidine were obtained from New England Nuclear (Boston, MA), and L-carboxyl-14C-tyrosine was obtained from Amersham (Arlington Heights, IL). Plastic culture plates were obtained from Costar (Cambridge, MA). Mouse monoclonal antibody to CAT was purchased from Chemicon (Temecula, CA), and rabbit anti-tyrosine hydroxylase was purchased from Eugene Tech International (Allendale, NJ). Biotinylated goat anti-mouse IgG, goat anti-rabbit fluorescein isothiocyanate (FITC), and streptavidin-Texas red were purchased from Jackson ImmunoResearch (Westgrove, PA). NGF was a generous gift from professor J. R. Perez-Polo (University of Texas Medical Branch, Galveston, TX). IGF-I was obtained from Amgen (Thousand Oaks, CA), and EGF was obtained from Collaborative Research (Bedford, MA). bFGF was a gift from Dr. F. F. Fuller, California Biotechnology Inc. (Mt. View, CA). IMR-32 cells were obtained from American Type Culture Collection (Rockville, MD).
Cell culture. IMR-32 cells were mated at a densitv of lo4 cells/well in poly-L-lysine-coated 96-well culture plates in DMEM supplemented with 10% FBS, penicillin (50 IU/ml), streptomycin (50 &ml), 2 mM glutamine, 1 mM nonessential amino acids, and 1 mM sodium pyruvate. The cultures were maintained at 37°C in a humidified atmosphere of 5% CO,, 95% air. Growth factors were added to the cultures at indicated concentrations at the time of plating. Unless otherwise indicated, half the media was removed and replaced with fresh media and growth factor after 3 d of incubation. Plates were assayed for CAT, TH, )H-thymidine uptake, and cell growth at given times as described below.
Cell proliferation and mitogenic activity. Cell proliferation was determined by directly counting single cell suspensions obtained by removing all media and treating each well with 25 ~1 of0.2% trypsin, 0.02% EDTA in Hank's Balanced Salt Solution. After 1 min, cells were triturated, 125 ~1 of culture media were added, and viable cells were counted by trypan blue exclusion. The viability of cells under these conditions was routinely >90%. For 3H-thymidine incorporation experiments, 2 x lo4 cells were cultured for 24 hr in DMEM-10% FBS. washed three times, and incubated for 24 hr in defined serum-free media [DMEM containing transferrin (100 mg/ml), putrescine (100 pm), selenium (30 nm), progesterone (20 nm), and insulin (2.5 fig/ml)]. The cells were then washed and refed with serum-free media, incubated with factors for 24 hr, and pulsed with 3H-thymidine (0.2 &/well) for 1 hr. The amount of 3H-thymidine incorporated by the cells was determined in a liquid scintillation counter after harvesting the cells onto glass fiber filters with a Brand1 Harvester (Gaithersburg, MD). The level of 3H-thymidine uptake was then normalized to the number of cells that excluded trypan blue in identically treated sister cultures.
CAT activity. Choline acetyltransferase activity in extracts of IMR-32 cells was determined by a modification of the method of Fonnum (1969) , measuring the formation of 3H-acetylcholine from 'H-acetylCoA and unlabeled choline, as previously described for spinal cord cultures (McManaman et al., 1988) . The reaction solution contained 0.1% NP-40. 5 mM NaH,PO,. 150 mM NaCl. 10 mM EDTA. 1.5 mM choline chloride, 0.1 mMese&e sulfate, 0.5 'mg/ml bovine serum albumin, and 0.1 mM 3H-acetyl-CoA (specific activity, 32 pCi/pmol). Naphthylvinyl pyridine was used to verify that the acetyltransferase activity was due to CAT and not the result of nonspecific acetyltransferase activity (Cavallito et al., 1970) . CAT activity was normalized to cell number by dividing the amount of 'H-acetylcholine synthesized per well by the number of cells in identically treated sister cultures.
Tvrosine hvdroxvlase. Tyrosine hydroxylase activity was determined by acoupled nonenzymatic decarboxylation of 14C-L-dopa, formed from 14C-L-tvrosine (Okuno and Fuiisawa. 1983) . as modified for 96-well culture plates (Bostwick and Le, 1991) . Briefly, the medium was removed and the cells were solubilized by adding 25 ~1 of 50 mM TrisHCl, pH 7.4, containing 0.2% Triton X-100, to each well and incubating for 30 min on ice. The reaction was initiated by adding 16.6 ~1 of icecold 0.45 M 2-[N-morpholinolethanesulfonic acid, pH 6.2, 2500 U of catalase, 2.3 mM dithiothreitol, 4.7 mM ascorbic acid, 2.3 mM 6-MePtH,, and 96 PM 14C-tyrosine (54.8 mCi/mmol) to each well and incubating at 37°C for 20 min. The decarboxylation was then initiated by the addition of 41.6 pl of 16.5 mM potassium ferricyanide and 10 mM o-chloromecuribenzenesulfonic acid in 50 mM Tris. pH 8.0. The released 14C-CO, was adsorbed onto Whatman #3 filter paper pretreated with methylbenzethonium hydroxide. After cooling, the adsorbed radioactivity was determined in a liquid scintillation counter. The amount of TH activity was normalized to cell number as described above for CAT activity. All TH activity is reported as the amount of 14C-tyrosine hydrolyzed/ 1 hr/cell. Zmmunojluorescence. IMR-32 cells were plated in DMEM-10% FBS at a density of 2.5 x lo4 cells on poly-r.-lysine (5 mg/ml) treated glass coverslips (12 mm) placed in 24-well plates. Factors were added at the time of plating and again every other day of culture. After 1 O-12 d, the coverslips were washed in PBS, fixed in 4% paraformaldehyde for 15 min, washed with PBS, and then permeabilized by incubating in 1% Triton X-100, 2% goat serum in PBS, for 2 hr. The cultures were then incubated with monoclonal antibody to CAT or polyclonal antibody to TH antibodies (diluted 1: 100 and 1: 1000, respectively, in 1% goat serum, 0.05% Tween 20) overnight at 4°C washed in PBS containing 0.05% Tween 20, and incubated with biotinylated goat anti-mouse IgG (diluted 1:300 in 1% goat serum, 0.05% Tween 20) for 1 hr. The coverslips were washed and incubated with streptavidin-Texas red (1:300) or FITC-conjugated goat anti-rabbit IgG (diluted 1:200 in 1% goat serum, 0.05% Tween 20) for 30 min, rinsed, and mounted in 90% glycerol. The number of immunoreactive cells was quantified by counting 300 cells per slide in triplicate, at 200 x or 400 x power using a Nikon Optiphot fluorescent microscope.
Growthfactor activities. Preliminary doseresponse experiments were performed to verify the activities of bFGF, CDF, EGF, NGF, and IGF-1. The activities of bFGF, EGF, and IGF-1 were verified by their ability to enhance 3H-thymidine proliferation in 3T3 fibroblasts (McManaman et al., 1989) . The activity of NGF was verified by its ability to increase neurite outgrowth in PC-12 cells (Green and Ruckenstein, 1989 ). CDF's activity was determined by its ability to enhance CAT activity in embryonic day 14 (E 14) rat spinal cord cultures (McManaman et al., 1988) .
Results CDF and bFGF dlflerentially afect CAT and TH activity in IMR-32 cells IMR-32 cells contain low but detectable basal levels of CAT activity that increase in direct proportion to cell number during culture. When basal CAT activity is normalized to cell number, the average (three separate experiments) specific CAT activity (CAT/cell) of control cells (0.14 f 0.0 1 fmol/hr/cell) remains constant over the culture period (Fig. 1) . The addition of CDF increases the specific CAT activity to 0. As shown in Figure 2 , the specific TH activity (TH/cell) of IMR-32 cultures treated with CDF remains identical to that of control cells throughout the culture period. On the other hand, bFGF markedly enhances the development of TH in IMR-32 cells. In cultures treated with bFGF for 3 d, the average specific TH activity was 0.11 f 0.0 1 fmol/hr/cell (N = 3) compared to 0.05 + 0.009 fmol/hr/cell (N = 3) for controls. After 6 d of culture, the specific TH activity of bFGF-treated cells increased to 0.75 + 0.08 fmol/hr/cell (N = 3), while that of control and CDF-treated cells decreased to 0.03 + 0.008 fmol/hr/cell (N = 3).
The efects of CDF and bFGF are dose dependent
The effects of both CDF and bFGF on CAT activity are dose dependent (Fig. 3A) . After 6 d of treatment, the mean (iV = 3) half-maximal effect of CDF on CAT specific activity was 11 .O + 2.5 @ml (0.5 nM), while that of bFGF was 25.1 f 3.8 ng/ ml (1.4 nM). The effect of bFGF on TH activity is also dose dependent. As shown in Fig. 3B , the mean (N = 3) half-maximal effect of bFGF TH specific activity was 21.9 + 4.6 rig/ml (1.2 nM), which is comparable to the half-maximal dose required to decrease CAT activity. Cell density d@erentially aflects the actions of bFGF and CDF
The influence of cell density on the actions of CDF and bFGF was determined by treating cells plated at 1, 2.5, 5, and 10 x lo4 cells/well with saturating amounts of CDF or bFGF and assaying for CAT or TH after 3 d. After this period in culture, low-density cultures (1 and 2 x 1 O4 cells/well) were still in log phase, while high-density cultures (5 and 10 x lo4 cells/well) were confluent (data not shown). As shown in Table 1 , cell density does not influence CDF's effect on CAT. At all plating densities, CDF increased CAT activity approximately twofold over control cultures. By comparison, cell density has mixed effects on bFGF's actions. There was no effect of cell density on the bFGF-mediated decrease in CAT activity. In both low and high density cultures, bFGF decreased the CAT specific activity to the same extent (Table 1 ). In contrast, the effect of bFGF on TH specific activity was markedly enhanced in high-density cultures.
CDF and bFGF do not affect each other's actions
The above experiments demonstrate that CDF and bFGF differentially affect CAT and TH development in IMR-32 cells.
To determine if the action of one factor affects that of the other, IMR-32 cells were treated simultaneously with saturating amounts of both factors and assayed for CAT and TH activity after 6 d of culture. As shown in Figure 4 , the bFGF-mediated decrease in CAT specific activity is the same for both control and CDF-treated cultures (34.5% f 5.2 in control cultures and 38.1% + 6.5 in CDF-treated cultures). In accordance with this result, CDF does not interfere with bFGF's effect on TH (Fig.   4B ).
IMR-32 cells d@erentially express CAT and TH in response to CDF and bFGF
The effects of CDF and bFGF on the expression of CAT and TH in IMR-32 cells were also analyzed by double-label immunofluorescence ( Table 2 . In control cultures, less than 10% of the cells were positive for either CAT or TH. Following CDF treatment, however, nearly all of the cells were CAT positive, but fewer than 10% expressed detectable TH immunoreactivity. In contrast, in cultures treated with bFGF the majority of the cells were positive for TH, while the number of CAT-positive cells was identical to controls. To determine if a single cell is capable of expressing both CAT and TH, IMR-32 cultures were simultaneously treated with CDF and bFGF. Because bFGF treatment decreases the specific CAT activity of the cells, it was necessary to prolong treatment with the factors for 12 d. In agreement with the results obtained with 6 d cultures, untreated cells did not express detectable CAT or TH immunoreactivity (data not shown). However, following combined treatment with CDF and bFGF, 75.9% f 10.7 (N = 3) of the cells were reactive with both antibodies (Figure 6 ).
CDF and bFGF d$er in their effects on cellular proliferation and 3H-thymidine incorporation into IMR-32 cells
The effects of growth factors on cell proliferation and 'H-thymidine incorporation are summarized in Table 3 . In serumcontaining medium, IMR-32 cells have a doubling time of 35 hr. The addition of CDF does not affect this growth rate, nor does it alter the level of 3H-thymidine incorporation in serumfree media. In contrast, the addition of bFGF both decreases the doubling time of IMR-32 cells in serum-containing media to 24 hr and stimulates 3H-thymidine incorporation in serumfree media by 50% over controls.
The eflects of NGF, IGF-I, and EGF direr from those of CDF and bFGF IMR-32 cells were also treated with NGF, IGF-I, and EGF for 6 d and assayed for CAT and TH activity (Fig. 7A,B) . IGF-I treatment produced a small increase in the average (N = 3) The levels of CAT and TH activity are shown as the percentage of the activity in control cultures. Each value is the average k SD from two separate experiments in which triplicate culture cells were treated with 5 ni.,r CDF and 3 nM bFGF and assayed after 3 d. The basal levels of CAT and TH activity per cell did not significantly change during the culture period.
specific CAT activity (0.20 f 0.02 fmol/hr/cell) but did not studies, we do not yet know if these increases reflect actions at affect TH specific activity. The effect of IGF-I on CAT activity transcriptional or translational levels. Furthermore, there have is dose dependent with a mean half-maximal activity at 2 nM.
been reports suggesting that the activities of both CAT and TH In contrast, NGF and EGF, in concentrations ranging from 0.5 can be increased by posttranslational modifications (Rydel and to 50 nM, did not affect either CAT or TH activity. The effects Greene, 1987; Casper and Davies, 1989 ). Although we cannot of these various factors on the proliferation of IMR-32 cells are directly rule out the possibility that in addition to increasing shown in Table 3 . Similar to the effects ofbFGF, NGF treatment protein levels, CDF and bFGF may alter enzyme activities, produced a small increase in cell proliferation and 3H-thymidine neither agent has produced acute effects on CAT or TH activincorporation. In contrast, there was no effect of IGF-I, EGF, ities. Thus, it is unlikely that CDF or bFGF alters the enzymatic or CDF on cell number or thymidine incorporation.
activities of CAT or TH.
Discussion
It is well known that certain neurons are capable of expressing more than one transmitter phenotype. It may be that at certain stages of development, neurons are multipotential in this regard, until transmitter choice is determined by some environmental cue. The experiments described here demonstrate that two identified, naturally occurring molecules can differentially regulate a neuronal cell line to adopt one or another mode of transmitter expression. CDF, a 22 kDa protein isolated from muscle that affects cholinergic development in vitro and rescues motoneurons in vivo, specifically induces CAT development in IMR-32 cells but does not affect TH. Basic FGF is a ubiquitous 18 kDa mitogenic growth factor with neuroactive effects on a number of neuronal subtypes in vivo and in vitro. In contrast to CDF, bFGF specifically induces TH and decreases CAT in IMR-32 cells. Those IMR-32 cells that express CAT and/or TH do not constitute separate subpopulations of cells. Thus, the opposing effects of CDF and bFGF are most likely due to the differential regulation of neurotransmitter expression within a single bipotential cell type.
While the actions of CDF appear to be specific for CAT expression, bFGF appears to affect both CAT and TH expression. Similar to its effect on TH, bFGF's effects on CAT activity increase over time. Therefore, it is unlikely that bFGF directly inhibits this enzyme. bFGF also does not appear to interfere directly with CDF's induction of CAT, since the percentage reduction of CAT activity is the same in the presence or the absence of CDF stimulation. However, we cannot exclude the possibility that bFGF may interfere with CDF's actions. Finally, it would appear that bFGF's effects on CAT are separate and distinct from its effects on TH. This conclusion is supported by both (1) the different time courses of bFGF's effects and (2) the differential influence of cell density on bFGF's actions on TH and CAT.
Factors that induce the expression of CAT while decreasing the expression of TH have previously been identified. For example, LIF, MANS (membrane-associated neurotrophic factor), and CNTF all enhance the expression of CAT and decrease TH expression in sympathetic neurons (Saadat et al., 1989; Rao et While CDF and bFGF enhance the expression of either CAT and TH, respectively, as is apparent from immunofluorescence CAT activity, and raise the possibility that bFGF may play a role in regulating the choice of neurotransmitter phenotype. bFGF has previously been shown to enhance CAT activity in cultures of rat spinal cord (McManaman et al., 1989) septal neurons (Knusel et al., 1990 ) ciliary ganglia (Vaca et al., 1989) , PC-12 cells, and LA-N-2 cells (McManaman and Crawford, 199 1). Thus, bFGF's effects on phenotypic properties appear to be variable and dependent on cell type. Cell density has been shown to influence the induction CAT and/or TH in several different cell types (Edgar and Thoenen, 1978; Lucas et al., 1979; Acheson and Thoenen, 1983; Hefti et al., 1985b, Adler and Black, 1986; Kessler, 1986; Kirshner et al., 1986; C&per and Davies, 1988) . Although the mechanisms of this effect are unknown, specific membrane proteins may mediate the density-dependent actions. For example, MANS has been shown to be involved in cell contact-mediated changes al., 1990). On the other hand, although factors in neural tubeconditioned media enhance adrenergic expression and suppress cholinergic expression in neural crest cells (Howard and Bronner-Fraser, 1986 ) the identities of these agents have not been established. Our results provide the first demonstration of a purified growth factor increasing TH activity and decreasing et al. l Neurotransmitter Development i n Neuroblastoma Cel l s in cholinergic expression (Lombard-Golly et al., 1990) . Our results show that although cell density does not by itself alter CAT or TH expression in IMR-32 cells, it does influence the effects of bFGF on TH expression. Furthermore, the effects of cell density on growth factor actions appear to be selective. In IMR-32 cells cell density does not influence the effects of either bFGF or CDF on CAT activity.
Previous reports have shown that bFGF can induce both proliferation and differentiation in several mesoderm-and neuroectoderm-derived cell types (Gospodarowicz et al., 1986) . Stemple et al. (1988) have demonstrated that the effects ofbFGF on proliferation and morphologic differentiation are distinct in PC-12 cells. We show that the effects of bFGF on phenotypic differentiation and proliferation are also distinct, since increases in TH levels are normalized to cell number, and there is increased immunofluorescent staining of individual IMR-32 cells after bFGF treatment. By contrast, CDF induction of CAT occurs in the absence of any effect on cell proliferation. These latter results are in agreement with previous studies demonstrating that CDF does not affect cell proliferation in either rat spinal cord cultures, mouse 3T3 fibroblasts, or human neuroblastoma cells (McManaman et al., 1988 (McManaman et al., , 1989 McManaman and Crawford, 199 1) . Thus, in addition to their differential effects on phenotypic differentiation, CDF and bFGF actions differ with respect to induction of cell proliferation.
The effects of IGF-I, NGF, and EGF on neurotransmitter phenotype also appear to be selective. Only IGF-I specifically induces a modest increase in CAT activity, without affecting TH. Previous reports show that IGF-I can induce cell proliferation in the SH-SYSY neuroblastoma cell line (Mattsson et al., 1986) . In IMR-32 cells, however, IGF-I does not affect cell growth, suggesting that the increase in CAT activity occurs independently of these processes. Interestingly, there is no effect of NGF on neurotransmitter activity, even though it does stimulate the proliferation of these cells as shown here and in previous reports (Ludecke and Unsicker, 1990) as well as neuronal precursor cells (Cattaneo and McKay, 1990 ) and early developmental chromaffin cells (Lillien and Claude, 1985) . The actions of NGF, therefore, need not be coupled to the expression of neurotransmitter enzymes. In contrast to the effects the other growth factors studied here, EGF had no effect on neurotransmitter phenotype or cell proliferation. Thus, our results suggest that a given growth factor may exhibit a diversity of actions on neurotransmitter development and that these actions are dependent on cell type and/or differentiation state of the cell.
